| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |